• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY LAP-BAND AP LARGE W/ ACCESS PORT I; ADJUSTABLE GASTRIC BAND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY LAP-BAND AP LARGE W/ ACCESS PORT I; ADJUSTABLE GASTRIC BAND Back to Search Results
Model Number B-2245
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Irritation (1941); Regurgitation (2259)
Event Date 04/13/2017
Event Type  Injury  
Manufacturer Narrative
Taper ii.Device labeling addresses the reported event as follows: adverse events: it is important to discuss all possible complications and adverse events with your patient.Complications which may result from the use of this product include the risks associated with the medications and methods utilized in the surgical procedure, the risks associated with any surgical procedure and the patient's degree of intolerance to any foreign object implanted in the body.Ulceration, gastritis, gastroesophageal reflux, heartburn, gas bloat, dysphagia, dehydration, constipation, and weight regain have been reported after gastric restriction procedures.Other adverse events considered related to the lap-band system that occurred in fewer than 1% of subjects included: esophagitis, gastritis, hiatal hernia, pancreatitis, abdominal pain, hernia, incisional infection, infection, redundant skin, dehydration, gi perforation, diarrhea, abnormal stools, constipation, flatulence, dyspepsia, eructation, cardiospasm, hematemesis, asthenia, fever, chest pain, incision pain, contact dermatitis, abnormal healing, edema, paresthesia, dysmenorrhea, hypochromic anemia, band leak, cholecystitis, esophageal dysmotility, esophageal ulcer, esophagitis, port displacement, port site pain, spleen injury and wound infection.Warnings: patients should be advised that the lap-band ap system is a long-term implant.Explant (removal) and replacement surgery may be indicated at any time.Medical management of adverse reactions may include explantation.Revision surgery for explantation and replacement may also be indicated to achieve patient satisfaction.
 
Event Description
Reported as: a patient with the lap-band system was reported to have a "lap-band device removal." it was noted that patient suffered from persistent reflux due to esophagitis.
 
Manufacturer Narrative
Supplement #1 - medwatch sent to fda on 30/aug/2017.Device evaluation summary: the device was returned for analysis, and visual examination confirmed the connector type as taper ii.Visual inspection noted the entire lap-band system was returned, with the port tubing separated, approximately 1.0 inch away from the ss connector.Scratches were noted on the port, and port holes.Needle marks were noted on the outer surface of the port.The band ring and shell were noted to be discolored, and were light brown in appearance.Brown particles were noted on the inner surface of the shell.White particles were noted on the outer surface of the shell.A fill inspection test was performed, and no blockage was noted when di water was passed through the port septum, or through the port tubing.An air leak test was performed, and no leakage was noted.Under microscopic analysis, both the ends of the band tubing and the port tubing were noted to have striated edges, consistent with surgical end cuts, and device removal activities.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAP-BAND AP LARGE W/ ACCESS PORT I
Type of Device
ADJUSTABLE GASTRIC BAND
Manufacturer (Section D)
APOLLO ENDOSURGERY
1120 s. captial tx hwy
bldg. 1 suite 300
austin TX 78746
Manufacturer (Section G)
ALLERGAN
global park free zone
900 global park
la aurora de heredia,
CS  
Manufacturer Contact
laura leboeuf
1120 s. captial of texas hwy
bldg 1, ste. 300
austin, TX 78746
5122795141
MDR Report Key6678007
MDR Text Key78724062
Report Number3006722112-2017-00216
Device Sequence Number1
Product Code LTI
UDI-Device Identifier10811955020190
UDI-Public10811955020190
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/11/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/29/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date11/24/2009
Device Model NumberB-2245
Device Catalogue NumberB-2245
Device Lot Number1521855
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/09/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received08/11/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/27/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ALLERGY MEDICATION; AMBIEN; B-12; BLOOD PRESSURE MEDICATION; CARAFAT; CINGULAR; NEXIUM; VITAMIN D
Patient Outcome(s) Required Intervention;
Patient Age56 YR
-
-